Heartflow (NASDAQ:HTFL) Trading 6.1% Higher – Should You Buy?

Heartflow, Inc. (NASDAQ:HTFL)’s share price traded up 6.1% during mid-day trading on Monday . The company traded as high as $29.76 and last traded at $29.21. 139,429 shares were traded during trading, a decline of 70% from the average session volume of 468,548 shares. The stock had previously closed at $27.53.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on HTFL shares. Zacks Research upgraded shares of Heartflow to a “hold” rating in a research report on Wednesday, September 3rd. Morgan Stanley initiated coverage on Heartflow in a report on Tuesday, September 2nd. They set an “equal weight” rating and a $35.00 price objective on the stock. Stifel Nicolaus raised their target price on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Heartflow in a research note on Monday. Finally, JPMorgan Chase & Co. upped their target price on shares of Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Four equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Heartflow presently has a consensus rating of “Hold” and an average price target of $38.60.

Heartflow Stock Up 4.5%

The company has a fifty day simple moving average of $33.04.

Heartflow (NASDAQ:HTFL) last released its earnings results on Friday, September 19th. The company reported ($1.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The company had revenue of $43.42 million for the quarter, compared to analyst estimates of $43.20 million.

Hedge Funds Weigh In On Heartflow

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. TFC Financial Management Inc. acquired a new position in shares of Heartflow in the third quarter worth about $40,000. Emerald Mutual Fund Advisers Trust acquired a new stake in shares of Heartflow during the third quarter worth approximately $4,418,000. TrueMark Investments LLC bought a new stake in shares of Heartflow in the third quarter worth $918,000. Baillie Gifford & Co. acquired a new stake in Heartflow in the third quarter valued at $101,182,000. Finally, Y Intercept Hong Kong Ltd acquired a new position in Heartflow in the third quarter worth about $234,000.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.